What are the physical symptoms of early prostate cancer

Treatments for early prostate cancer include surgery, radiotherapy, and hormone therapy. Common symptoms include dysuria, frequent urination, and hematuria, which may be related to abnormal prostate tissue growth. Dysuria is manifested by a thinning or interrupted urine stream, frequent urination means getting up multiple times at night to urinate, and hematuria may be accompanied by changes in urine color. These symptoms are usually related to the invasion of prostate tissue by cancer cells, but they need to be confirmed through medical examinations.

1. Dysuria is one of the common symptoms of early prostate cancer. Patients may feel that their urine flow has become thinner, their urination has been interrupted, or they need to strain to urinate. This condition is related to the abnormal proliferation of prostate tissue compressing the urethra. Patients are advised to undergo prostate-specific antigen PSA testing and rectal examination to confirm the diagnosis. If prostate cancer is confirmed, treatments include radical prostatectomy, external beam radiotherapy, and brachytherapy. Radical prostatectomy eliminates cancer cells by removing the entire prostate and surrounding tissues, external beam radiotherapy uses high-energy rays to kill cancer cells, and brachytherapy acts directly on the tumor by implanting radioactive particles.

2. Frequent urination is also a typical symptom of early prostate cancer, especially getting up several times at night to urinate. This situation may be related to the enlarged prostate compressing the bladder. Patients are advised to reduce the amount of water they drink before bed and avoid stimulating beverages such as coffee and alcohol. If symptoms persist, transrectal ultrasound and prostate biopsy are required to confirm the diagnosis. Treatments include hormone therapy and chemotherapy. Hormone therapy slows the growth of cancer cells by inhibiting the secretion of androgens or blocking their effects, while chemotherapy uses drugs to kill cancer cells. Commonly used hormone therapy drugs include leuprolide and bicalutamide, and chemotherapy drugs include docetaxel and cabazitaxel.

3. Hematuria is another important symptom of early prostate cancer, which manifests as a change in urine color or blood in the urine. This condition may be related to cancer cells invading the urethra or bladder. Patients are advised to drink plenty of water to dilute the urine and avoid strenuous exercise. If hematuria persists, cystoscopy and CT scan are required to confirm the diagnosis. Treatments include cryotherapy and immunotherapy. Cryotherapy freezes and kills cancer cells at extremely low temperatures, while immunotherapy attacks cancer cells by activating the patient's own immune system. Commonly used immunotherapy drugs include Siprussez-T and Pembrolizumab.

Symptoms of early prostate cancer, such as dysuria, frequent urination, and hematuria, may be related to abnormal proliferation of prostate tissue and need to be confirmed through medical examinations. Treatments include surgery, radiotherapy, hormone therapy, chemotherapy, cryotherapy, and immunotherapy. Patients should choose the appropriate treatment plan according to the doctor's advice. Regular PSA testing and digital rectal examinations can help detect and treat prostate cancer early, improve cure rates and quality of life.